Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sepsis Diagnostics Market Growth Fueled by Faster Pathogen Detection Needs

By LabMedica International staff writers
Posted on 14 Sep 2026

Sepsis diagnostics support early detection of bloodstream infections and sepsis by helping clinicians identify pathogens, assess disease severity, and guide antimicrobial therapy in emergency, ICU, inpatient, and critical care settings. More...

The global sepsis diagnostics market is projected to grow from USD 0.83 billion in 2026 to USD 1.22 billion by 2031, representing a compound annual growth rate (CAGR) of 7.9%. This growth is being driven by the high incidence of sepsis and bloodstream infections, increased adoption of rapid molecular and syndromic diagnostics, broader use of biomarker-based testing, and rising demand for faster pathogen identification and treatment decision support.

These are the latest findings of MarketsandMarkets (Delray Beach, FL, USA), a management consulting firm.

Increasing focus on antimicrobial stewardship is also supporting demand for diagnostic tools that can help clinicians select, adjust, or discontinue antimicrobial therapy more quickly. Blood culture systems, molecular diagnostic platforms, immunoassays, antimicrobial susceptibility testing, mass spectrometry, and clinical chemistry-based tests all play important roles in sepsis diagnosis and patient management. The growing need to reduce delays in treatment decisions is expected to continue supporting adoption of automated and rapid diagnostic technologies.

Based on product, assays, kits, and reagents accounted for the largest share of the global sepsis diagnostics market in 2025, representing 40.7% of revenue. This segment is supported by recurring use across blood culture testing, immunoassays, molecular diagnostics, antimicrobial susceptibility testing, and biomarker-based sepsis assessment. Demand for pathogen detection kits, sepsis biomarker assays, PCR-based reagents, and syndromic testing panels is expected to continue supporting the segment’s leading position.

By technology, blood culture and microbiology testing accounted for the largest share of the sepsis diagnostics market in 2025, reflecting their established role in detecting bloodstream infections and supporting antimicrobial susceptibility testing. Molecular diagnostics is expected to grow strongly during the forecast period, driven by increasing adoption of PCR, multiplex PCR panels, sequencing, and other methods that enable faster pathogen identification and resistance marker detection.

By pathogen type, bacterial sepsis held the largest market share in 2025, supported by the high burden of bacterial bloodstream infections, hospital-acquired infections, and ICU-related infections. Laboratory tests accounted for the largest share by test type, while point-of-care tests are expected to grow rapidly as hospitals seek faster sepsis screening and decentralized decision support in emergency and critical care settings. Whole blood remained the leading sample type, given its central role in blood culture testing and molecular pathogen detection.

Hospitals and specialty clinics dominated the market in 2025, accounting for 62.7% of revenue, driven by the high sepsis burden in emergency departments, ICUs, inpatient wards, and critical care settings. Geographically, North America held the largest regional share in 2025 at 43.2%, supported by advanced hospital infrastructure, strong antimicrobial stewardship initiatives, and high adoption of automated blood culture systems and molecular diagnostics. Asia Pacific is expected to record the fastest growth, driven by rising healthcare expenditure, expanding hospital infrastructure, and increasing adoption of automated and molecular diagnostic platforms.

Related Links
MarketsandMarkets


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.